07.23.25 -- The Mighty CDMOs Producing API

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.

Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

Understand how softgel technology enhances rapid drug absorption and precise dosing, offering crucial benefits for high-potency oncology treatments.

From the moment radiolabeled drugs are made, it’s a race to get them to patients. Radioactive decay is just one of many complications. Here’s one company’s approach.

Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.

Review highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

To meet ambitious orphan drug development timelines, CDMOs must be able to scale quickly to progress from early clinical development to validation and commercial launch.

Leverage expert small molecule solutions from preclinical development to commercial manufacturing, with strengths in large-scale oral solids, advanced formulations, and more.

Explore services that are critical for ensuring drug safety, compliance, and efficiency with advanced technology and regulatory adherence to streamline these processes.

We integrate scientific information gathered at the material, process, and instrument levels to decode the root causes of common tableting issues, such as capping, lamination, picking, and sticking.